Cancer
Neoplasm of Uncertain Histogenesis
CI-CAN-00000034Explore in graph →
Non-malignant20,280 active trials259 approved drugs3,813 evidence items
Loading cancer entity…
Cancer
CI-CAN-00000034Explore in graph →
Clinical trials
91,351 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01368523 | Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107A2109 Trial | completed | Phase 4 | 19 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 16, 2016 | clinicaltrials |
| NCT02953730 | The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents | completed | Phase 4 | 9 | Chinese Academy of Medical SciencesOTHER | 1 | Nov 3, 2016 |
| clinicaltrials |
| NCT02567331 | A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer | completed | Phase 4 | 28 | Hoffmann-La RocheINDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT02581423 | A Study of Capecitabine (Xeloda) in the Adjuvant Treatment of Participants With Resected Colon Cancer | completed | Phase 4 | 63 | Hoffmann-La RocheINDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT01041612 | Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi | completed | Phase 4 | 120 | Taewoong Medical Co., Ltd.INDUSTRY | 2 | Oct 21, 2016 | clinicaltrials |
| NCT00220194 | A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer | completed | Phase 4 | 100 | San Bernardino Urological Associates Medical Group IncOTHER | 1 | Oct 14, 2016 | clinicaltrials |
| NCT00845221 | Glivec in Pediatric Chronic Myeloid Leukemia (CML) | completed | Phase 4 | 44 | Poitiers University HospitalOTHER | 1 | Oct 11, 2016 | clinicaltrials |
| NCT01961544 | Eribulin Mesylate Phase IV Clinical Trial in Korean Patients With Metastatic or Locally Advanced Breast Cancer(ESKIMO) | completed | Phase 4 | 101 | Eisai Korea Inc.INDUSTRY | 1 | Oct 7, 2016 | clinicaltrials |
| NCT00949910 | An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 4 | 6,586 | Hoffmann-La RocheINDUSTRY | 51 | Oct 5, 2016 | clinicaltrials |
| NCT01664975 | Treatment of Peripheral T-cell Lymphoma | completed | Phase 4 | 100 | Mingzhi ZhangOTHER | 1 | Oct 5, 2016 | clinicaltrials |
| NCT02316327 | Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab | completed | Phase 4 | 19 | Fundacion Clinic per a la Recerca BiomédicaOTHER | 1 | Oct 5, 2016 | clinicaltrials |
| NCT02320734 | Deep Neuromuscular Relaxation in Patients for Thoraco-laparoscopic Esophagectomy(DEPTH) | completed | Phase 4 | 66 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Sep 19, 2016 | clinicaltrials |
| NCT01609660 | Impact of Probiotics on the Intestinal Microbiota | completed | Phase 4 | 33 | Federal University of Minas GeraisOTHER | 0 | Sep 12, 2016 | clinicaltrials |
| NCT01371643 | Surgical Debulking of Pituitary Adenomas | completed | Phase 4 | 41 | NYU Langone HealthOTHER | 1 | Aug 29, 2016 | clinicaltrials |
| NCT02880072 | Absorption of Orally Ingested Phosphate in Refeeding Syndrome | completed | Phase 4 | 12 | Jens Rikardt AndersenOTHER | 1 | Aug 26, 2016 | clinicaltrials |
| NCT01066884 | A Study of First or Second Line Treatment With Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 4 | 5 | Hoffmann-La RocheINDUSTRY | 1 | Aug 24, 2016 | clinicaltrials |
| NCT01575574 | Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis(PRIGA) | completed | Phase 4 | 74 | Sara VareaOTHER | 1 | Aug 23, 2016 | clinicaltrials |
| NCT01719757 | PROspective Non-interventional Open laBEl Trial for TARGIN in Korean Patients With Cancer Pain(PROBE) | completed | Phase 4 | 359 | Mundipharma Korea LtdINDUSTRY | 1 | Aug 19, 2016 | clinicaltrials |
| NCT02566096 | Efficacy of Transverses Abdominis -Plane Block With Bupivacaine Versus Bupivacaine With Morphine Postoperatively | completed | Phase 4 | 60 | Assiut UniversityOTHER | 1 | Jul 15, 2016 | clinicaltrials |
| NCT00817479 | Tumor Gene Expression in Women With Ovarian Cancer | completed | Phase 4 | 20 | University of ChicagoOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT02268890 | A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma | completed | Phase 4 | 18 | Johnson & Johnson Taiwan LtdINDUSTRY | 1 | Jul 11, 2016 | clinicaltrials |
| NCT01649635 | Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer(PROSPECTA) | completed | Phase 4 | 45 | SanofiINDUSTRY | 1 | Jul 6, 2016 | clinicaltrials |
| NCT02805153 | PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy | completed | Phase 4 | 215 | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.INDUSTRY | 0 | Jun 20, 2016 | clinicaltrials |
| NCT02805205 | PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent Neutropenia | completed | Phase 4 | 484 | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.INDUSTRY | 0 | Jun 20, 2016 | clinicaltrials |
| NCT02805218 | PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy | completed | Phase 4 | 410 | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.INDUSTRY | 0 | Jun 20, 2016 | clinicaltrials |
| NCT02805166 | PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving Chemotherapy | completed | Phase 4 | 420 | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.INDUSTRY | 0 | Jun 17, 2016 | clinicaltrials |
| NCT00613275 | Patient Navigation in the Safety Net:CONNECTeDD | completed | Phase 4 | 4,038 | Boston Medical CenterOTHER | 1 | Jun 15, 2016 | clinicaltrials |
| NCT01328054 | A Study in Cancer Patients to Evaluate the Effect of Lapatinib on the QTc Interval | completed | Phase 4 | 58 | GlaxoSmithKlineINDUSTRY | 1 | Jun 8, 2016 | clinicaltrials |
| NCT00451906 | A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer. | completed | Phase 4 | 2,252 | Hoffmann-La RocheINDUSTRY | 40 | May 24, 2016 | clinicaltrials |
| NCT00742222 | Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer(EXIBT) | completed | Phase 4 | 63 | Xoft, Inc.INDUSTRY | 1 | May 17, 2016 | clinicaltrials |
| NCT02773251 | The Effect of Guardix-solution for the Prevention of Postoperative Intestinal Adhesion and Intestinal Obstruction After Laparoscopic Pelvic Cavity Surgery | completed | Phase 4 | 60 | Bucheon St. Mary's HospitalOTHER | 0 | May 17, 2016 | clinicaltrials |
| NCT01561287 | A Comparison of Dermal Autograft to AlloDerm in Breast Reconstruction | completed | Phase 4 | 48 | University of KentuckyOTHER | 1 | May 11, 2016 | clinicaltrials |
| NCT02173964 | Pinverin Application Trial to Reduce Bowel Uptake of FDG (Fluorodeoxyglucose) | completed | Phase 4 | 58 | Seoul National University HospitalOTHER | 1 | Apr 15, 2016 | clinicaltrials |
| NCT02246023 | Fractionated Versus Target-controlled Propofol Administration in Bronchoscopy | completed | Phase 4 | 78 | Daniel FranzenOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT00626054 | Comparison of Two Methods of Administration of a PEG Solution(PEG) | completed | Phase 4 | 400 | Rabin Medical CenterOTHER | 1 | Apr 13, 2016 | clinicaltrials |
| NCT01083199 | Global Performance Evaluation of the AMS CONTINUUM™ Device | completed | Phase 4 | 10 | American Medical SystemsINDUSTRY | 2 | Apr 12, 2016 | clinicaltrials |
| NCT01231204 | Prevention of Post-Mastectomy Breast Pain Using Ambulatory Continuous Paravertebral Blocks | completed | Phase 4 | 60 | University of California, San DiegoOTHER | 1 | Apr 11, 2016 | clinicaltrials |
| NCT00829465 | Clinical Research of Licartin Combined With TACE in the Treatment of Unresectable Hepatocellular Carcinoma | completed | Phase 4 | 400 | Eastern Hepatobiliary Surgery HospitalOTHER | 0 | Apr 1, 2016 | clinicaltrials |
| NCT01317615 | RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation | completed | Phase 4 | 49 | Novartis PharmaceuticalsINDUSTRY | 1 | Mar 30, 2016 | clinicaltrials |
| NCT00365508 | Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking | completed | Phase 4 | 642 | Fox Chase Cancer CenterOTHER | 1 | Mar 29, 2016 | clinicaltrials |
| NCT02708056 | Sugammadex Given for the Reversal of Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in Infants | completed | Phase 4 | 26 | Baskent UniversityOTHER | 0 | Mar 15, 2016 | clinicaltrials |
| NCT00770588 | Assess the Efficacy, Safety and Tolerability of Gefitinib (Iressa® 250mg) as Maintenance Therapy in Locally Advanced or Metastatic (Stage IIIB/IV) Non Small Cell Lung Cancer (NSCLC)(INFORM) | completed | Phase 4 | 296 | AstraZenecaINDUSTRY | 1 | Feb 8, 2016 | clinicaltrials |
| NCT01658280 | Conventional Versus Ultrasound-guided Transbronchial Needle Aspiration for the Diagnosis of Hilar/Mediastinal Lymphadenopathies | completed | Phase 4 | 253 | Azienda Ospedaliero, Universitaria Ospedali RiunitiOTHER | 1 | Feb 3, 2016 | clinicaltrials |
| NCT01402089 | Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients | completed | Phase 4 | 54 | Markus JoergerOTHER | 1 | Feb 2, 2016 | clinicaltrials |
| NCT01641458 | Pharmacology-driven Dosing of Fluoropyrimidines in Cancer Patients(FLOXTOX2) | completed | Phase 4 | 37 | Cantonal Hospital of St. GallenOTHER | 1 | Feb 2, 2016 | clinicaltrials |
| NCT01609543 | A Study of Tarceva (Erlotinib) in First Line in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With EGFR Mutations | completed | Phase 4 | 62 | Hoffmann-La RocheINDUSTRY | 3 | Feb 1, 2016 | clinicaltrials |
| NCT00526175 | LAL-BR/2001: Study Treatment to Low Risk ALL | completed | Phase 4 | 150 | PETHEMA FoundationOTHER | 1 | Jan 20, 2016 | clinicaltrials |
| NCT02000531 | Progression Free Survival (PFS) Using Erlotinib for Non-Small-Cell Lung Cancer (NSCLC) in Chinese Population | completed | Phase 4 | 45 | Hoffmann-La RocheINDUSTRY | 1 | Jan 13, 2016 | clinicaltrials |
| NCT01809106 | RCT Comparing the Analgesic Efficacy of 4 Therapeutic Strategies Based on 4 Different Major Opioids (Fentanyl, Oxycodone, Buprenorphine vs Morphine) in Cancer Patients With Moderate/Severe Pain, at the Moment of Starting 3rd Step of WHO Analgesic Ladder.(CERP) | completed | Phase 4 | 518 | Mario Negri Institute for Pharmacological ResearchOTHER | 1 | Dec 24, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Nov 16, 2016source: clinicaltrials